Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.330 NOK
−106.68 M NOK
190.81 M NOK
190.77 M
About HOFSETH BIOCARE AS
Sector
CEO
Jon Olav Ødegård
Headquarters
Ålesund
Website
Founded
2009
ISIN
NO0010598683
FIGI
BBG003FWLJ29
Hofseth Biocare ASA engages in the development, marketing, and sale of biomarine ingredients. Its products include ProGo Bioactive Peptides, OmeGo Salmon Oil, CalGo Calcium Collagen Complex, and Shop Branded Products. The company was founded by Roger Hofseth in 2000 and is headquartered in Alesund, Norway.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of HBCO is 1.245 NOK — it has decreased by −7.78% in the past 24 hours. Watch HOFSETH BIOCARE ASA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange HOFSETH BIOCARE ASA stocks are traded under the ticker HBCO.
HBCO stock has fallen by −11.39% compared to the previous week, the month change is a −21.94% fall, over the last year HOFSETH BIOCARE ASA has showed a −52.84% decrease.
HBCO reached its all-time high on Nov 26, 2019 with the price of 10.800 NOK, and its all-time low was 1.220 NOK and was reached on Feb 16, 2017. View more price dynamics on HBCO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
HBCO stock is 8.43% volatile and has beta coefficient of −0.33. Track HOFSETH BIOCARE ASA stock price on the chart and check out the list of the most volatile stocks — is HOFSETH BIOCARE ASA there?
Today HOFSETH BIOCARE ASA has the market capitalization of 550.85 M, it has decreased by −5.59% over the last week.
Yes, you can track HOFSETH BIOCARE ASA financials in yearly and quarterly reports right on TradingView.
HOFSETH BIOCARE ASA is going to release the next earnings report on Feb 14, 2025. Keep track of upcoming events with our Earnings Calendar.
HBCO net income for the last quarter is −35.01 M NOK, while the quarter before that showed −17.56 M NOK of net income which accounts for −99.33% change. Track more HOFSETH BIOCARE ASA financial stats to get the full picture.
No, HBCO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 65.00 employees. See our rating of the largest employees — is HOFSETH BIOCARE ASA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HOFSETH BIOCARE ASA EBITDA is −91.00 M NOK, and current EBITDA margin is −52.39%. See more stats in HOFSETH BIOCARE ASA financial statements.
Like other stocks, HBCO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HOFSETH BIOCARE ASA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HOFSETH BIOCARE ASA technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HOFSETH BIOCARE ASA stock shows the sell signal. See more of HOFSETH BIOCARE ASA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.